Mahindra Manulife Innovation Opp Fund
The Scheme shall seek to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies following innovation theme.
Growthvine rating: 1/5 — ranked #167 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹10.39 (as of 2026-10-01) |
|---|
| AUM | ₹236 Cr |
|---|
| Expense ratio | 2.10% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Renjith Sivaram Radhakrishnan |
|---|
| Exit load | 0.5% for redemption within 3 months |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −10.55% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Market cap allocation
| Large cap | 43.1% |
|---|
| Mid cap | 36.9% |
|---|
| Small cap | 20.0% |
|---|
Concentration
| Top 5 holdings | 14.9% |
|---|
| Top 10 holdings | 27.2% |
|---|
| Total holdings | 51 |
|---|
Top holdings
- Triparty Repo — 5.0%
- Eternal Limited — 3.8%
- Bajaj Finance Limited — 2.9%
- ICICI Bank Ltd. — 2.8%
- Aditya Birla Capital Ltd — 2.7%
- Torrent Pharmaceuticals Ltd. — 2.7%
- One 97 Communications Limited — 2.6%
- ACUTAAS CHEMICALS LIMITED — 2.4%
- Karur Vysya Bank Ltd. — 2.4%
- Aster DM Healthcare Limited — 2.4%
Top sectors
- Banking & Financial — 10.2%
- Pharma & Biotech — 9.9%
- Finance & Investments — 7.0%
Calendar-year track record
No calendar-year history.